| Serial Number | 79182715 |
| Word Mark | BIOSE |
| Filing Date | Friday, July 3, 2015 |
| Status | 707 - PARTIAL SECTION 71 ACCEPTED |
| Status Date | Friday, January 13, 2023 |
| Registration Number | 5056931 |
| Registration Date | Tuesday, October 11, 2016 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 26, 2016 |
| Goods and Services | [ Arranging and conducting of educational colloquiums, conferences, seminars and events for scientific purposes in the field of microbiota, of probiotics as pharmaceutical preparations, of the probiotics industry, of good practice in the field of microbiota, of probiotics, of changes to regulations relating to probiotics and microbiota ] |
| Goods and Services | [ Pharmaceutical products made with the microbiota, namely, bacteria, probiotics and tribiotics for treating gynecological disorders, intestinal disorders, gastroenterological disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat, allergies; chemical or biological pharmaceutical preparations for pharmaceutical, medical and sanitary purposes, namely, microbiota, bacteria, probiotics and tribiotics for treating gynecological disorders, intestinal disorders, gastroenterological disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat, allergies; sanitary and medical preparations, namely, bacteria for use in the composition of biological pharmaceuticals for treating gynecological disorders, intestinal disorders, gastroenterological disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat, allergies; biological or chemical preparations for pharmaceutical, medical use, toilet, namely, probiotics, tribiotics in capsules, capsules and sachets for treating or preventing the gastroenterological disease, gyncological, ear, nose and throat, dermatological, allergic, immune or inflammatory, diseases associated with an imbalance in the vaginal or intestinal flora, flatulence, diarrhea, abdominal pain, spasms, or for improving regulation of intestinal transit; vaginal capsules for treating gynecological diseases; preparations for medical use, namely, antifungals, antimycotics, antiflatulent agents, antidiarrheic agents, antispasmodics, antiinflammatories or antibiotics; disinfectants for hygiene care of patients suffering from gastroenterological diseases, imbalance of the intestinal flora, gynecological diseases, imbalance of the vaginal flora; nutritional supplements, namely, food beverages, bars and meal replacement substances adapted for medical use, dietetic purposes, treating or preventing gynecological disorders, gastroenterological, intestinal disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat; nutritional supplements, namely, meal replacement foods, beverages, bars made from a combination of probiotics, minerals and/or vitamins; vitamin preparations, namely, vitamin supplements; medical preparations for slimming; mineral food supplements ] |
| Translation of Words in Mark | The wording "BIOSE" has no meaning in a foreign language. |
| Goods and Services | Laboratory services for the provision of scientific analysis and research services, medical, pharmaceutical, pharmacological, bacteriological, chemical and microbiological, design and production of pharmaceutical preparations, probiotics, tribiotics for others; consulting in production of pharmaceutical preparations; quality control; testing in laboratory; services for assessing the efficiency of pharmaceuticals; auditing and auditing pharmaceutical manufacturing processes; packaging design services; kitchen design of preventive quality assurance and quality control relating to the manufacture of pharmaceutical preparations; auditing and testing standards and practices in the field of the manufacture of probiotics, tribiotics, ensure compliance with governmental regulations and industrial practices, practices quality control and quality assurance; conducting pharmaceutical research projects and technical project studies; engineering; provision of information and data relating to medical and scientific research in the field of pharmaceuticals, probiotics, and clinical trials relating to scientific research and development; provision and exchange of knowledge, industrial know-how and data relating to scientific research and development; provision and exchange of information and data exchange between scientists, manufacturers and health authorities relating to pharmaceutical regulatory affairs and the application thereof to probiotics; expertise services and technical advice in the field of scientific research for medical and pharmaceutical purposes, in the field of probiotics; development and maintenance of data banks and databases; extraction and retrieval of information and data mining; managing of working groups bringing together scientists and manufacturers to resolve problems in connection with probiotics; research and drafting of information provided by scientific research in the field of medical research, pharmaceutical, pharmacological in regulatory affairs in the field of probiotics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Friday, January 13, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Friday, January 13, 2023 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 25, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BIOSE INDUSTRIE |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | Arpajon Sur Cere F-15130 FR |
| Party Name | BIOSE |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | BIOSE |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | BIOSE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Event Date | Event Description |
| Wednesday, February 24, 2016 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Tuesday, February 23, 2016 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, February 25, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 1, 2016 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 4, 2016 | REFUSAL PROCESSED BY MPU |
| Friday, May 27, 2016 | ASSIGNED TO LIE |
| Thursday, February 25, 2016 | ASSIGNED TO EXAMINER |
| Thursday, March 3, 2016 | NON-FINAL ACTION WRITTEN |
| Friday, March 4, 2016 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, March 4, 2016 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, March 26, 2016 | REFUSAL PROCESSED BY IB |
| Tuesday, May 17, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 2, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 2, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 13, 2017 | FINAL DISPOSITION PROCESSED |
| Tuesday, June 14, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, June 16, 2016 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Monday, June 20, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, July 6, 2016 | NOTICE OF PUBLICATION |
| Tuesday, July 26, 2016 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 11, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, January 11, 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, February 13, 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, February 17, 2017 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Friday, March 3, 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, March 13, 2017 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Friday, September 11, 2020 | CHANGE OF OWNER RECEIVED FROM IB |
| Wednesday, September 13, 2023 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, July 1, 2022 | TEAS SECTION 71 RECEIVED |
| Tuesday, January 10, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, January 13, 2023 | REGISTERED - PARTIAL SEC 71 ACCEPTED |
| Friday, January 13, 2023 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Tuesday, October 31, 2023 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| Thursday, July 24, 2025 | INTERNATIONAL REGISTRATION RENEWED |
| Saturday, September 23, 2023 | INVALIDATION PROCESSED |
| Saturday, September 23, 2023 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |